BamSEC and AlphaSense Join Forces
Learn More

Harrow Inc Com – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: HROW    
Share price (8/17/26): $39.48    
Market cap (8/17/26): $1.480 billion
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K/A 57 pages Agreement and Plan of Merger by and Among Harrow, Inc. Harrow Acquisition Sub, Inc. Melt Pharmaceuticals, Inc. and Donald Bradford Osborne, as Stockholder Representative Dated September 24, 2025
12/34/56
EX-2.1
from 8-K 76 pages Stock Purchase Agreement by and Among Imprimis Pharmaceuticals, Inc., Dennis Saadeh, Tina Sulic-Saadeh, South Coast Specialty Compounding (D/B/a Park Compounding) and Seller Representative Dated as of November 26, 2014
12/34/56
EX-2.1
from 8-K 57 pages Membership Interest Purchase Agreement Among John Scott Karolchyk and Bernard Covalesky and Imprimis Pharmaceuticals, Inc. Dated as of February 10, 2014
12/34/56
EX-2
from SC 13D 6 pages Waiver Agreement
12/34/56
EX-2
from SC 13D 10 pages Schedule 13d Under the Securities Exchange Act of 1934
12/34/56
EX-2
from SC 13D 6 pages Waiver Agreement
12/34/56
EX-2.1
from 8-K 36 pages Asset Purchase Agreement Dated as of June 26, 2011 by and Among Transdel Pharmaceuticals, Inc., as Seller and Cardium Healthcare, Inc., as Purchaser and Cardium Therapeutics Inc
12/34/56
EX-2.3
from 8-K 1 page Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.2
from 8-K 3 pages Certificate of Merger of Trans-Pharma Acquisition Corp. (A Delaware Corporation) With and Into Trans-Pharma Corporation (A Nevada Corporation) (Pursuant to Section 252(c) of the Delaware General Corporation Law)
12/34/56
EX-2.1
from 8-K 38 pages Agreement of Merger and Plan of Reorganization by and Among Transdel Pharmaceuticals, Inc. Trans-Pharma Acquisition Corp. and Trans-Pharma Corporation Dated as of September 17, 2007 Agreement of Merger and Plan of Reorganization
12/34/56